About: Norbert Pardi

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Norbert Pardi Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

Assistant Professor (Microbiology)

Attributes	Values
rdf:type	wdno:P227 Item
description	wetenschapper (nl) дослідник (uk) biológus (hu) Assistant Professor (Microbiology) (en)
rdfs:label	Norbert Pardi (de) Norbert Pardi (en) Norbert Pardi (es) Norbert Pardi (fr) Norbert Pardi (it) Norbert Pardi (nl) Norbert Pardi (pl) Pardi Norbert (hu)
skos:prefLabel	Norbert Pardi (de) Norbert Pardi (en) Norbert Pardi (es) Norbert Pardi (fr) Norbert Pardi (it) Norbert Pardi (nl) Norbert Pardi (pl) Pardi Norbert (hu)
name	Norbert Pardi (de) Norbert Pardi (en) Norbert Pardi (es) Norbert Pardi (fr) Norbert Pardi (it) Norbert Pardi (nl) Norbert Pardi (pl) Pardi Norbert (hu)
given name	wds:Q88256458-35323FE5-232C-4BA0-B8FE-7E3C6B1AEBD3
given name	Norbert
instance of	wds:Q88256458-ABDDDB77-5608-430D-A225-D7CC9A3A31DC
instance of	Homo sapiens
skos:altLabel	Norbert Pardi (tr)
occupation	wds:Q88256458-2A3BB975-7D80-4ED2-9181-940FE8AE1762
employer	wds:Q88256458-ac8bb1d3-4290-5eb4-d855-fbe8c2eac155
place of birth	wds:Q88256458-faef9c8d-4135-ca4e-f1d5-4608882307d0
sex or gender	wds:q88256458-b503f74f-4629-a628-f441-233ae701c5ea
VIAF ID	wds:Q88256458-29afff5e-48f1-ef46-8024-ffe3f50ec04d
GND ID	wds:Q88256458-ac5ffc0d-4aea-e4da-e641-2872fc44ebf4
country of citizenship	wds:Q88256458-502720cd-4d18-87a1-2722-4179ac957a7c
date of birth	wds:Q88256458-8e1704d5-4652-f04b-443f-299464d0e6ec
educated at	wds:Q88256458-15774722-4ee2-34b2-d5e9-2fa494538a78
family name	wds:Q88256458-5c1b9a7e-4000-052c-c090-c16bbcfc196f
VIAF ID	http://viaf.org/viaf/3526169757873008010006
occupation	microbiologist
employer	University of Pennsylvania
place of birth	Kisújszállás
sex or gender	male
VIAF ID	3526169757873008010006
country of citizenship	Hungary
date of birth	1980-01-01 00:00:00Z (xsd:dateTime)
educated at	Franz Joseph University
family name	Pardi
ORCID iD	wds:Q88256458-017AA4D1-03E0-4AD5-93EE-96B3E0644CF8
Dimensions author ID	wds:Q88256458-CEBCF9DA-FC77-4F94-8021-F757A620F263
ORCID iD	https://orcid.org/0000-0003-1008-6242
ORCID iD	0000-0003-1008-6242
Dimensions author ID	0702476476.77
MTMT author ID	wds:Q88256458-6B3DBE91-56E3-4D49-B8A8-254EF6932A34
MTMT author ID	10025199
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q88256458
is author of	TATA binding protein associated factor 3 (TAF3) interacts with p53 and inhibits its function In vitro transcription of long RNA containing modified nucleosides Daxx-like protein of Drosophila interacts with Dmp53 and affects longevity and Ark mRNA level. Expression kinetics of nucleoside-modified mRNA delivered in lipid nanoparticles to mice by various routes Nucleoside Modified mRNA Vaccines for Infectious Diseases HPLC purification of in vitro transcribed long RNA. Zika virus protection by a single low-dose nucleoside-modified mRNA vaccination New Kids on the Block: RNA-Based Influenza Virus Vaccines. mRNA vaccines - a new era in vaccinology. Nucleoside-modified mRNA immunization elicits influenza virus hemagglutinin stalk-specific antibodies Administration of nucleoside-modified mRNA encoding broadly neutralizing antibody protects humanized mice from HIV-1 challenge Anti-PfGARP activates programmed cell death of parasites and reduces severe malaria Nucleoside-modified mRNA vaccines induce potent T follicular helper and germinal center B cell responses. Selective targeting of nanomedicine to inflamed cerebral vasculature to enhance the blood-brain barrier Nucleoside-modified mRNA vaccination partially overcomes maternal antibody inhibition of de novo immune responses in mice D614G Spike Mutation Increases SARS CoV-2 Susceptibility to Neutralization Increased surface expression of HIV-1 envelope is associated with improved antibody response in vaccinia prime/protein boost immunization. Characterization of HIV-1 Nucleoside-Modified mRNA Vaccines in Rabbits and Rhesus Macaques Nucleoside-modified mRNA encoding HSV-2 glycoproteins C, D, and E prevents clinical and subclinical genital herpes Purification of mRNA Encoding Chimeric Antigen Receptor Is Critical for Generation of a Robust T-Cell Response The Transcription Factor T-bet Resolves Memory B Cell Subsets with Distinct Tissue Distributions and Antibody Specificities in Mice and Humans PECAM-1 directed re-targeting of exogenous mRNA providing two orders of magnitude enhancement of vascular delivery and expression in lungs independent of apolipoprotein E-mediated uptake Measuring the Adjuvant Activity of RNA Vaccines Recent advances in mRNA vaccine technology Lipid nanoparticle encapsulated nucleoside-modified mRNA vaccines elicit polyfunctional HIV-1 antibodies comparable to proteins in nonhuman primates A Multi-Targeting, Nucleoside-Modified mRNA Influenza Virus Vaccine Provides Broad Protection in Mice A Single Immunization with Nucleoside-Modified mRNA Vaccines Elicits Strong Cellular and Humoral Immune Responses against SARS-CoV-2 in Mice In vivo effects of abolishing the single canonical sumoylation site in the C-terminal region of Drosophila p53. Messenger RNA-Based Vaccines Against Infectious Diseases Protection against herpes simplex virus type 2 infection in a neonatal murine model using a trivalent nucleoside-modified mRNA in lipid nanoparticle vaccine An HSV-2 nucleoside-modified mRNA genital herpes vaccine containing glycoproteins gC, gD, and gE protects mice against HSV-1 genital lesions and latent infection 2772. HCMV gB Ectodomain Subunit and gB mRNA Vaccines Reduce AD-3 Immunodominance and Elicit More Durable Antibody Responses Than gB/MF59 Immunization HCMV glycoprotein B nucleoside-modified mRNA vaccine elicits antibody responses with greater durability and breadth than MF59-adjuvanted gB protein immunization SARS-CoV-2 mRNA Vaccines Foster Potent Antigen-Specific Germinal Center Responses Associated with Neutralizing Antibody Generation Vaccination with Messenger RNA: A Promising Alternative to DNA Vaccination
is author of	wds:Q40405926-28C5E84E-6C1D-49B2-B200-18A9E47596DA wds:Q58721961-27F07961-E136-4C87-A12F-58904015AAA9

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 196 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software